Results of the MAGNIFY study for high-risk indolent non-hodgkin lymphoma patients

Kathryn Kolibaba, MD of US Oncology Research discusses the MAGNIFY study and its impact on high-risk indolent NHL patients at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/21/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts